($ 1 = 0.9116 Swiss francs).
ZURICH (Reuters) – Switzerland has signed a contract with Moderna to secure early access to the COVID-19 vaccine the U.S. biotech business is developing, the federal government said on Friday.
Switzerland will get 4.5 million doses of the vaccine, enough to vaccinate 2.25 million individuals if as anticipated two doses are needed per patient.
The government is also speaking with other vaccine companies and has actually allocated 300 million Swiss francs ($ 329 million) to the task.
( Reporting by John Revill; modifying by John Stonestreet).